FRA/VEN (FRA/VEN)

Frankfurt Stock Exchange: FRA/VEN · EUR

€78.0

+0.56 (+0.7%)· Recorded snapshot

Market cap	39.6B
Revenue (ttm)	6B
Net income (ttm)	230.8M
EPS (ttm)	€0.47
P/E (trailing)	167.3x
P/E (forward)	102.2x
Dividend	€1.78 (2.28%)
Volume	0

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 6B
Net income (ttm): 230.8M
EPS (ttm): €0.47
P/E (trailing): 167.3x
P/E (forward): 102.2x
Market cap: 39.6B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E102.2

P25 n/aP50 n/aP75 n/a

Trailing P/E167.3

P25 n/aP50 n/aP75 n/a

ROE1.9

P25 n/aP50 n/aP75 n/a

ROIC3.5

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All FRA/VEN indicators

Market & fundamental data

Available fields

221

Groups with data

Currency

USD

Showing 221 of 221 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	EUR
Country	United States
Country code	DE
Earnings date	2026-10-27
Employees	542
Employees change	44
Employees growth	8.84%
Enterprise value	EUR 51.2B
Exchange	Frankfurt Stock Exchange
Financial currency	USD
Financial report date	2026-09-30
First seen	2026-05-10
Fiscal year end	December
Founded	1983
Industry	REIT - Healthcare Facilities
Is primary listing	No
ISIN number	US92276F1003
Last earnings date	2026-10-27
Last refreshed	2026-10-28
Market cap	EUR 39.6B
Next earnings date	2026-10-30
Price	EUR 78.04
Price currency	EUR
Sector	Real Estate
SIC code	6798
Stock price date	2026-10-27
Symbol	fra/VEN
Website	https://www.ventasreit.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	246.07x
Average P/E ratio (3Y)	177.83x
Average P/E ratio (5Y)	541.51x
Earnings yield	0.6%
EV/Earnings	222x
EV/EBIT	59.83x
EV/EBITDA	23.15x
EV/Sales	8.43x
Forward P/E	102.25x
Graham number	17.06028
Graham upside	-78.14%
Lynch fair value	EUR 2.51
Lynch upside	-96.78%
P/(OCF - SBC) ratio	25.04x
P/B ratio	2.75x
P/E ratio	167.31x
P/OCF ratio	24.45x
P/S ratio	6.64x
Price / tangible book value	3.04x
Price/EBITDA ratio	18.21x
Sector forward P/E	7.32x
Sector P/E	4.97x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	14.58%
EBITDA margin	36.45%
Gross margin	39.57%
Operating margin	14.58%
Pretax margin	3.1%
Profit margin	3.87%
Profit per employee	EUR 425,781
Profitable quarters	9
Profitable years	2
Revenue per employee	EUR 11M
ROA	2.14%
ROA (5Y)	1.76%
ROCE	3.4%
ROE	1.86%
ROE (5Y)	0.57%
ROIC	3.45%
ROIC (5Y)	2.93%
SBC / revenue	0.66%
Tax / revenue	-0.92%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	0.34%
EPS growth (Q)	-9.14%
EPS growth (QoQ)	-9.14%
EPS growth 10Y	-10.93%
EPS growth 3Y	267.38%
EPS growth 5Y	-0.36%
EPS growth years	3
Net income growth	10.1%
Net income growth (Q)	-1.01%
Net income growth (QoQ)	-7.35%
Net income growth 3Y	278.65%
Net income growth 5Y	5.52%
Net income growth quarters	8
Net income growth years	3
OCF growth	18.22%
OCF growth 10Y	3.04%
OCF growth 3Y	17.09%
OCF growth 5Y	7.43%
Revenue growth	22.07%
Revenue growth (Q)	22%
Revenue growth (QoQ)	6.5%
Revenue growth 10Y	7.1%
Revenue growth 3Y	15.79%
Revenue growth 5Y	12.47%
Revenue growth quarters	20
Revenue growth years	5

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Depreciation and amortization	EUR 1.3B
EBIT	EUR 869.1M
EBITDA	EUR 2.2B
EPS	EUR 0.47
Funds from operations (FFO)	EUR 1.4B
Gross profit	EUR 2.4B
Income taxes	EUR -54.6M
Investing cash flow	EUR -4.2B
Net cash flow	EUR -406.8M
Net income	EUR 230.8M
Operating cash flow minus SBC	EUR 1.6B
Operating income	EUR 869.1M
Revenue	EUR 6B
Stock-based compensation	EUR 38.1M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	EUR 26.32
Debt / EBITDA	5.07
Debt / equity	0.77
Goodwill	EUR 939.3M
Interest coverage	1.56
Net cash (debt)	EUR -11B
Net cash / market cap	-27.75%
Net debt / EBITDA	5.05
Net debt / equity	0.76
Piotroski F-Score	6
Property, plant and equipment	EUR 24.5B
Shareholders' equity	EUR 14.4B
Tangible book value	EUR 13B
Tangible book value per share	EUR 24.58
Total assets	EUR 27B
Total cash	EUR 177.9M
Total debt	EUR 11.2B
Total liabilities	EUR 12.6B

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.24
Current ratio	0.49
Net working capital	EUR -883.4M
Quick ratio	0.13
Working capital	EUR -705.5M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-10.5%
Dividend growth	4.75%
Dividend growth (10Y)	-3.9%
Dividend growth (3Y)	2%
Dividend growth (5Y)	3.23%
Dividend growth years	0
Dividend payment date	2026-10-15
Dividend payment years	25
Dividend payout frequency	Quarterly
Dividend per share	EUR 1.78
Dividend yield	2.28%
Ex-dividend date	2026-09-30
Last dividend	EUR 0.46
Payout ratio	353.06%
Shareholder yield	-8.22%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	22.81%
10Y return CAGR	6.47%
10Y total return	87.12%
150-day SMA	EUR 75.92
15Y price change	100.28%
15Y return CAGR	9.34%
15Y total return	281.45%
1D price change	0.72%
1M price change	1.87%
1M total return	2.49%
1W price change	2.81%
1W total return	2.81%
1Y price change	28.92%
1Y return CAGR	32.13%
1Y total return	32.1%
20-day SMA	EUR 74.77
200-day SMA	EUR 74.49
20Y price change	151.8%
20Y return CAGR	9.52%
20Y total return	516.86%
3M price change	-11.37%
3M total return	-10.83%
3Y price change	94.38%
3Y return CAGR	28.58%
3Y total return	112.6%
50-day SMA	EUR 76.47
50-day SMA vs 200-day SMA	50over200
52-week high	EUR 87.98
52-week high date	2026-07-27
52-week low	EUR 59.86
52-week low date	2025-10-30
5Y price change	64.75%
5Y return CAGR	14.25%
5Y total return	94.62%
6M price change	9.78%
6M total return	11.09%
All-time high	EUR 87.98
All-time high date	2026-07-27
All-time low	EUR 14.53
All-time low date	2008-12-02
Average true range (ATR)	EUR 0.84
Average volume	6.5
Change from 52-week high	-11.3%
Change from 52-week low	30.37%
Change from all-time high	-11.93%
Change from all-time low	433.24%
Change from open	0%
Day's gap	0.72%
High price	EUR 78.04
Low price	EUR 78.04
Monthly RSI	65.35
Open price	EUR 78.04
Previous close	EUR 77.48
Price vs 150-day SMA	2.06%
Price vs 20-day SMA	3.63%
Price vs 200-day SMA	4.01%
Price vs 50-day SMA	1.32%
Relative volume	20
RSI	59.16
Sharpe ratio	1.05
Sharpe ratio (3Y)	0.98
Sharpe ratio (5Y)	0.48
Sortino ratio	1.83
Sortino ratio (3Y)	1.74
Sortino ratio (5Y)	0.93
Volume	0
Weekly RSI	53.72
YTD price change	15.09%
YTD total return	17.93%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	510.5M
Shares change (QoQ)	4.26%
Shares change (YoY)	10.5%
Shares held by insiders	0.37%
Shares held by institutions	103.88%

Deeper analysis on FRA/VEN

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this FRA/VEN report

Is a complete FRA/VEN research report available?

No complete published report is available for fra/VEN (FRA/VEN) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

FRA/VEN (FRA/VEN)

Price

Financial snapshot

Fair-value bridge

Latest news · FRA/VEN

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All FRA/VEN indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on FRA/VEN

Frequently asked questions